UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Diabetologia, ISSN 0012-186X, 1/2018, Volume 61, Issue 1, pp. 29 - 38
Diabetic retinopathy | Animal models | Medicine & Public Health | Human Physiology | Metabolic Diseases | Internal Medicine | Neurovascular unit | Review | Vasoregression | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hyperglycemia | Metabolites | Neurons | Analysis | Glucose | Dextrose | Oxidative stress | Retinopathy | Diabetes mellitus | Retina | Neuronal-glial interactions | Angiogenesis | Retinal degeneration | Pruning | Diabetes | Cellular stress response | Index Medicus
Journal Article
Diabetes (New York, N.Y.), ISSN 0012-1797, 01/2011, Volume 60, Issue 1, pp. 9 - 16
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Diabetes. Impaired glucose tolerance | Retinopathies | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Ophthalmology | Endocrine pancreas. Apud cells (diseases) | Humans | Mice, Transgenic | Diabetic Retinopathy - pathology | Diabetic Retinopathy - therapy | Erythropoietin - physiology | Neovascularization, Pathologic - pathology | Diabetic Retinopathy - physiopathology | Retina - physiology | Animals | Angiopoietin-1 - physiology | Mice | Receptor, TIE-2 - physiology | Hyperglycemia - physiopathology | Retina - pathology | Vascular Endothelial Growth Factor A - physiology | Neovascularization, Physiologic | Cell Movement | Inflammation - physiopathology | Causes of | Diabetic retinopathy | Complications and side effects | Development and progression | Diabetes | Index Medicus | Abridged Index Medicus | s in Diabetes
Journal Article
Diabetologia, ISSN 0012-186X, 11/2018, Volume 61, Issue 11, pp. 2412 - 2421
Angiogenesis | GLP-1 | Medicine & Public Health | Human Physiology | Proliferative retinopathy | Metabolic Diseases | DPP-4 | Internal Medicine | Linagliptin | Oxygen-induced retinopathy | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Human Umbilical Vein Endothelial Cells | Diabetic Retinopathy - drug therapy | Retina - metabolism | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Male | Linagliptin - therapeutic use | Oxygen - adverse effects | Retinal Neovascularization - metabolism | Vascular Endothelial Growth Factor A - metabolism | Vascular Endothelial Growth Factor A - genetics | Glucagon-Like Peptide 1 - genetics | Glucagon-Like Peptide-1 Receptor - genetics | Glucagon-Like Peptide-1 Receptor - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Retinal Neovascularization - genetics | Diabetic Retinopathy - etiology | Disease Models, Animal | Glucagon-Like Peptide 1 - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Mice, Inbred C57BL | Signal Transduction - genetics | Diabetic Retinopathy - metabolism | Animals | Signal Transduction - drug effects | Mice | Retinal Neovascularization - drug therapy | Retina - pathology | Antimitotic agents | Diabetic retinopathy | Analysis | Neovascularization | Antineoplastic agents | Gene expression | Vascular endothelial growth factor | Transcription factors | Oxygen | Retinopathy | Peptidase | Glucagon | Diabetes mellitus | c-Jun protein | Extracellular signal-regulated kinase | MAP kinase | Retina | JNK protein | Kinases | Endothelial cells | Vascular endothelial growth factor receptors | Signal transduction | Ischemia | Protein kinase | Glucagon-like peptide 1 | Umbilical vein | Index Medicus
Journal Article
Progress in retinal and eye research, ISSN 1350-9462, 03/2016, Volume 51, pp. 156 - 186
Diabetic retinopathy | Retina | Diabetes | Diabetic macular oedema | Pathogenesis | Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Diabetic Retinopathy - physiopathology | Diabetic Retinopathy - drug therapy | Animals | Bevacizumab - therapeutic use | Intravitreal Injections | Humans | Angiogenesis Inhibitors - therapeutic use | Laser Coagulation | Ranibizumab - therapeutic use | Diabetic Retinopathy - surgery | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Medical colleges | Care and treatment | Endothelial growth factors | Health aspects | Medical research | Medicine, Experimental | Risk factors | Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 10/2013, Volume 34, Issue 39, pp. 3035 - 3087
Prevention | Prognosis | Diagnostics | Diabetes mellitus | Pharmacological treatment | Cardiovascular disease | Coronary Interventions | Epidemiology | Impaired glucose tolerance | Patient management | Risk factors | Guidelines | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology
Journal Article